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Abstract 
Review on oculocutaneous albinism, with data on 
clinics, and the genes involved. 
Identity 
Other names 
Albinism, Oculocutaneous Albinism type 1 (OCA1) 
Oculocutaneous Albinism type 2 (OCA2) 
Oculocutaneous Albinism type 3 (OCA3) 
Oculocutaneous Albinism type 4 (OCA4) 
Oculocutaneous Albinism type 5 (OCA5) 
Oculocutaneous Albinism type 6 (OCA6) 
Oculocutaneous Albinism type 7 (OCA7) 
Tyrosinase-Negative Albinism 
Tyrosinase-Positive Albinism 
Note 
Oculocutaneous Albinism (OCA) is a group of 
congenital developmental disorder characterized by 
complete or partial loss of melanin in skin, hair and 
eye. OCA is caused due to defects in genes 
associated with melanin biosynthetic pathway. 
Depending on the gene mutated, OCA can be 
classified into Oculocutaneous Albinism type 1 
(OCA1), Oculocutaneous Albinism type 2 (OCA2), 
Oculocutaneous Albinism type 3 (OCA3) and 
Oculocutaneous Albinism type 4 (OCA4), 
Oculocutaneous Albinism type 5 (OCA5), 
Oculocutaneous Albinism type 6 (OCA6) and 
Oculocutaneous Albinism type 7 (OCA7). OCA1 
affects 1 per 40000 individuals in most populations  
(King et al., 2001) but is very uncommon among 
African-Americans.  
The overall prevalence of OCA2 is estimated to be 
1:36000 in USA, but it is a lot more common among 
the African Americans with a prevalence of 1:10000 
(Okoro, 1975). In fact, OCA2 affects 1 in 3900 of the 
population in the southern parts of Africa.  
OCA3 or Rufous oculocutaneous albinism has been 
estimated to affect 1:8500 individuals in Africa; 
however, it is very rare in any other populations as 
per published literature. OCA4 has been found to be 
the second largest rare form of albinism after OCA1 
in Japan. The 3 other forms of OCA are very rare. 
There is a single report till date for OCA5 in a 
consanguineous Pakistani family [Kausar et al., 
2013]. A few distinct cases of SLC24A5 mediated 
OCA6 - one from India, one from China, two 
patients from France, three from Portugal, one from 
Belgium and one from Syria, have been reported till 
date [Mondal et al., 2012; Wei et al., 2013; Fanny et 
al., 2014].  Nine Faroese patients and one Danish 
patient of Lithuanian origin harbored mutations in 
C10ORF11 gene representing OCA7 [ Gronskov et 
al., 2014].  
It is worth mentioning that in countries like India 
where endogamy prevails, the incidence of OCA 
would be higher than the world average. In fact, in 
India, a preponderance of homozygous mutations is 
found and OCA1 is caused majorly because of 
founder mutations (Chaki et al., 2005; Chaki et al. 
2006). 
Inheritance 
Oculocutaneous Albinism Ray K, et al. 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2016; 20(6) 353 
 
OCA is inherited in an autosomal recessive mode. 
However, recently, it has been hypothesized that the 
clinical spectrum of OCA depends on the 
pigmentation threshold of the patient. In 
genotypically darker complexion individuals such as 
in Africans, two mutations are needed to completely 
shut off the high pigmentation background; whereas 
in individuals with lighter complexion such as 
Caucasians, OCA can be manifested by the presence 
of one mutation and one hypomorphic allele (Chiang 
et al., 2008). 
Clinics 
OCA is characterized by partial or total absence of 
melanin in the skin, hair and eyes at birth. The 
absence of optimum content of melanin during 
embryogenesis acts as a cue to trigger defects in eye 
development that cannot be corrected. A portion of 
the retinal ganglion cell (RGC) axons, originally 
destined to the ipsilateral hemisphere of the dorsal 
lateral geniculate nuclei (dLGN) of the midbrain, 
misproject to the contralateral side, thereby resulting 
in the disruption of binocular vision (Lund, 1965; 
Guillery, 1971; Cooper and Pettigrew, 1979; Drager 
and Olsen, 1980; Lavado and Montoliu, 2006).  
The developmental defect concerned with abnormal 
nerve fibre projection has been discussed in details 
in a review by Ray et al., 2007 (Ray et al., 2007). 
Phenotype and clinics 
The reduction of melanin in peripheral retina results 
in a stereoscopic set of developmental defects in 
neuronal migration in the visual pathways leading to 
foveal hypoplasia, abnormal routing of the nerve 
fibers from the eye to brain with consequent low 
vision (reduced visual acuity usually in the range 
20/60 to 20/400 and refractive errors), photophobia, 
iris transillumination, nystagmus and strabismus. An 
OCA affected person is considered legally blind if 
he/she has a visual acuity of 20/200 (6/60) or less. 
The degree of severity of the eye features as well as 
skin pigmentation varies with the different subtypes 
of albinism. Due to loss of pigmentation, the iris 
looks hazel or light blue or in extreme cases as in 
OCA1, it is translucent to such an extent that it 
appears pink or red in ambient light. The skin 
remains white or only become slightly pigmented 
with time in case of OCA1 whereas the patients 
suffering from the other 3 types of albinism have 
residual pigmentation and look pinkish or yellowish. 
If unprotected from sun rays, hypopigmented skin in 
the albinistic individuals may develop erythema. 
Moreover, the reduction in melanin pigment in the 
skin results in an increased sensitivity to UV induced 
skin damage and subsequently non-melanotic skin 
cancers.  
It must be stated here that based on the severity of 
pigment loss, the most severe form of OCA viz. 
OCA1 can be sub-classified into two categories - (a) 
OCA1A: when the tyrosinase enzyme activity is 
completely lacking, and (b) OCA1B: when some 
residual activity is retained. The visual acuity of the 
OCA1A patients is greatly reduced; the degree of 
nystagmus, strabismus, photophobia are usually 
severe and the translucent iris that appear pink early 
in life, often become gray-blue with age. In case of 
OCA1A there is an absence of pigmentation 
throughout the patient's life. In contrast, in OCA1B, 
although there is little or no apparent melanin at 
birth, progressive melanization might occur with 
time. The range of pigmentation in OCA1B varies 
from little cutaneous pigment to nearly normal skin 
color and the phenotype is often influenced by 
ethnicity. OCA1B is called 'yellow OCA' due to the 
color of the hair, produced by pheomelanin 
synthesis. 
Neoplastic risk 
The loss of pigment often leads to non-melanotic 
skin cancers in form of Squamous Cell Carcinoma 
(SCC) and Basal Cell Carcinoma (BCC) (Mabula et 
al., 2012). Melanoma is rare in albino patients 
(Pehamberger et al., 1984). 
Treatment 
No specific treatment is available for OCA. 
Attention must be paid to avoidance of direct sun 
exposure. 
Evolution 
OCA1B patients although are born with almost no 
pigmentation, show a progressive melanization with 
age. 
Prognosis 
With proper protection from direct exposure from 
sun and visual aids like dome magnifiers, reading 
glasses, hand-held and stand magnifiers, patients 
should be able to lead a normal life. 
Genes involved and 
proteins 
Note 
OCA can be classified into seven major types viz. 
Oculocutaneous Albinism type 1 (OCA1), 
Oculocutaneous Albinism type 2 (OCA2), 
Oculocutaneous Albinism type 3 (OCA3) and 
Oculocutaneous Albinism type 4 (OCA4), 
Oculocutaneous Albinism type 5 (OCA5), 
Oculocutaneous Albinism type 6 (OCA6) and 
Oculocutaneous Albinism type 7 (OCA7). Each of 
the classical subtypes is caused due to defects in 7 
different genes independently. Table 1 shows the 
genes involved in OCA: 
Oculocutaneous Albinism Ray K, et al. 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2016; 20(6) 354 
 
 
Table 1: Causal genes and specific symptoms for 7 classical OCA syndromes. 
 
TYR 
Alias 
Monophenol monooxygenase, SHEP3, Tumor 
rejection antigen AB, LB24-AB, SK29-AB. 
Location 
11q14.3 
Note 
TYR codes for Tyrosinase protein, the rate limiting 
enzyme of melanin biosynthetic pathway. 
DNA/RNA 
Description 
The human tyrosinase gene consists of 5 exons and 
spans about 65 kb of the genome. 
Transcription 
It encodes a 2082 bp transcript (Accession No: 
NM_000372.4). 
Pseudogene 
TYR-like segment (TYRL, 11p11.2, MIM 191270) 
is a pseudogene of TYR, which contains sequences 
very similar to exons IV and V of TYR gene.  
It is hypothesized that duplication of TYR exons IV 
and V regions followed by 11q:11p translocation has 
given rise to the TYRL segment. 
Protein 
Description 
TYR (monophenol monoxygenase EC 1.14.18.1) 
encodes a ~80 kDa glycoprotein (Accession No: 
NP_000363.1) composed of 529 amino acids. TYR 
is a melanosomal membrane bound glycoenzyme 
with a type-3 copper active site.  
The mature TYR polypeptide includes an 18-amino 
acid long N-terminal signal peptide, six N-
glycosylation sites, two copper binding sites (CuA 
and CuB) and one transmembrane (TM) domain 
followed by a relatively short carboxyl tail. 
Expression 
TYR is mainly expressed in two cell types: (a) 
Melanocytes that are derived from neural crest cells 
colonizing within iris, cochlea, skin and choroids, 
and (b) Retinal pigment epithelial (RPE) cells that 
are derived from the optic cup. During mouse 
embryogenesis, the expression of TYR could be first 
detected from +16.5 days post coitum onwards in the 
skin melanocytes and from +10.5 days postcoitum 
onwards in the RPE cells (Beermann et al., 1992). 
Localisation 
TYR is a melanosomal membrane protein and the 
TM region anchors the bulk of the protein inside the 
melanosomal lumen. 
Function 
TYR catalyzes the rate limiting steps of melanin 
biosynthesis viz. hydroxylation of L-tyrosine to L-
DOPA and oxidation of L-DOPA to DOPAquinone.  
It also catalyzes the conversion of 5,6 
dihydroxyindole to Indole 5,6 Quinone and 
5,6,dihydroxyindole carboxylic acid to Indole 5,6 
quinone carboxylic acid. 
Oculocutaneous Albinism Ray K, et al. 
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Homology 
TYR, Tyrosinase Related Protein 1 (TYRP1) and 
Tyrosinase Related Protein 2 (TYRP2/DCT) 
represent a family of closely related gene products 
(with almost 40% amino acid identity) that share a 
common tertiary structure (Jimenez-Cervantes et al., 
1998; Kobayashi et al., 1998). These have been 
grouped together to form the TYRP family of genes. 
Mutations 
Germinal 
TYR mutations are responsible for OCA1. A few 
OCA2 mutations have been associated with 
autosomal recessive ocular albinism (AROA). 
OCA1 is an endoplasmic reticulum retention (ER) 
disorder and all the missense mutations that have 
been functionally characterized have yielded ER -
retained proteins. 
OCA2 (OCA2 melanosomal 
transmembrane protein) 
Alias 
P, Pink-eyed dilution protein homolog, D15S12, 
Melanocyte-specific transporter protein, EYCL, 
EYCL2, EYCL3, BOCA, BEY, BEY1, BEY2, 
HCL3, PED, SHEP1, oculocutaneous albinism II 
(pink-eye dilution (murine) homolog)1 
Location 
15q12 
Note 
OCA2 codes for OCA2 protein, hypothesized to be 
involved in the transport of tyrosine, the precursor to 
melanin synthesis, within the melanocyte. 
DNA/RNA 
Description 
The human OCA2 gene consists of 24 exons and 
spans ~344.5 kb of the genome. 
Transcription 
It encodes a 3154 bp transcript (Accession No: 
NM_000275.2). 
Protein 
Description 
OCA2 encodes a ~110 kDa protein (Accession No: 
NP_000266.2) composed of 838 amino acids. The 
OCA2 protein is thought to be a melanosomal 
multipass integral membrane protein (with 12 
predicted transmembrane domains) involved in 
small molecule transport, specifically tyrosine - a 
precursor of melanin. 
Expression 
Due to its localization in the melanosomal 
membrane, OCA2 is thought to be expressed in the 
melanocytes. 
Localisation 
OCA2 is hypothesized to be present in the 
melanosomal membrane of the melanocytes. 
Function 
The precise function of OCA2 has not been 
elucidated till date. However, the potential functions 
include: a) normal biogenesis of melanosomes 
(Rosemblat et al., 1998; Orlow and Brilliant et al., 
1999); b) for normal processing and transport of 
tyrosinase and other melanosomal proteins (Puri et 
al., 2000; Manga et al., 2001; Toyofuku et al., 2002; 
Chen et al., 2002); and c) maintenance of an acidic 
pH in melanosomes (Ni-Komatsu and Orlow, 2006). 
Homology 
Its sequence predicts that OCA2 has a homology to 
a superfamily of permeases (Rinchik et al., 1993; 
Lee et al., 1995). 
Mutations 
Germinal 
OCA2 mutations are responsible for OCA2. A few 
OCA2 mutations have been associated with 
autosomal recessive ocular albinism (AROA) too. 
TYRP1 (tyrosinase-related protein 1) 
Alias 
RP11-3L8.1, CAS2, CATB, GP75, SHEP11, TRP, 
TYRP, b-PROTEIN 
Location 
9p23 
Note 
TYRP1 codes for TYRP1 protein, hypothesized to 
be involved in melanin synthesis, stabilization of 
tyrosinase and modulating its catalytic activity, 
maintenance of melanosome structure and affects 
melanocyte proliferation and melanocyte cell death. 
Defects in this gene are the cause of rufous 
oculocutaneous albinism and oculocutaneous 
albinism type III. 
DNA/RNA 
Description 
The human TYRP1 gene consists of 8 exons and 
spans ~24.8 kb of the genome. 
Transcription 
It encodes a 2876 bp transcript (Accession No: 
NM_000550.2). 
Protein 
Description 
TYRP1 encodes a 60.7 kDa protein (Accession No: 
NP_000541.1) composed of 537 amino acids. The 
TYRP1 protein is thought to be a melanosomal 
membrane single-pass type I membrane protein. 
Expression 
TYRP1, similar to TYR, is mainly expressed in two 
cell types: (a) Melanocytes that are derived from 
neural crest cells colonizing within iris, cochlea, skin 
and choroids, and (b) Retinal pigment epithelial 
(RPE) cells that are derived from the optic cup. 
Localisation 
TYRP1 is hypothesized to be localized in 
melanosome membrane. 
Function 
Oxidation of 5,6-dihydroxyindole-2-carboxylic acid 
(DHICA) into indole-5,6-quinone-2-carboxylic acid. 
May regulate or influence the type of melanin 
synthesized. 
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Homology 
Belongs to the tyrosinase family. Homologous to 
murine brown locus. 
Mutations 
Germinal 
TYRP1 mutations are responsible for OCA3. 
SLC45A2 (solute carrier family 45 
member 2) 
Alias 
Membrane associated transporter protein, MATP, 
MELANOMA ANTIGEN AIM1, AIM1 
Location 
5p13.2 
Note 
SLC45A2 codes for SLC45A2 protein, hypothesized 
to be involved in the transport of substances required 
for melanin biosynthesis within the melanocyte. 
DNA/RNA 
Description 
The human SLC45A2 gene consists of 7 exons and 
spans 40.1 kb of the genome. 
Transcription 
It encodes a 1734 bp transcript (Accession No: 
NM_016180.3). 
Protein 
Description 
SLC45A2 encodes a ~58 kDa protein (Accession 
No: NP_057264.3) and composed of 530 amino 
acids. The protein is thought to be a melanosomal 
multipass membrane protein (contains 12 putative 
transmembrane domains) involved in small 
molecule transport. 
Expression 
Expressed in most melanoma cell lines and 
melanocytes. 
Localisation 
SLC45A2 is hypothesized to be present in the 
melanosomal membrane of the melanocytes. 
Function 
The precise function of SLC45A2 has not been 
elucidated till date. Studies on Medaka fish show 
that the SLC45A2/MATP plays an important role in 
pigmentation and probably functions as a membrane 
transporter in melanosomes (Fukamachi et al., 
2001). 
Homology 
Belongs to the glycoside-pentoside-hexuronide 
(GPH) cation symporter transporter (TC 2.A.2) 
family. 
Mutations 
Germinal 
SLC45A2 mutations are responsible for OCA4. 
Oculocutaneous Albinism 5 
(Autosomal Recessive) 
Location 
4q24 
Note 
This chromosomal locus harbors 14 genes, none of 
which are directly responsible for melanin 
biosynthesis 
DNA/RNA 
Description 
4q24 harbors 14 genes (CENPE, TACR3, CXXC4, 
TET2, PPA2, INTS12, GSTCD, NPNT, AIMP1, 
DKK2, PAPSS1, SGMS2, CYP2U1, HADH) with 
linkage interval of 3.84Mb. 
Transcription 
The underlying gene causing OCA5 has not yet been 
identified. 
Protein 
Function 
4q24 is a chromosomal locus harbouring about 14 
genes in it with a linkage interval of 3.84 Mb. 
Though none of those 14 genes are known to have 
any role in melanin synthesis, but studies are being 
done to ascertain the role of this locus and to identify 
the underlying gene. 
Mutations 
Germinal 
Though inheritance indicates germinal origin of the 
mutations, the causal gene is yet to be recognized. 
SLC24A5 (solute carrier family 24 
(sodium/potassium/calcium 
exchanger), member 5) 
Alias 
Solute Carrier Family 24 
(Sodium/Potassium/Calcium Exchanger), Member 
5, JSX, OCA6 
Location 
15q21.1 
Note 
SLC24A5 codes for a cation exchanger which is 
probably involved in ion transport in melanosomes. 
DNA/RNA 
Description 
The human SLC24A5 gene consists of 5 exons and 
spans 21.701 kb of the genome 
Transcription 
This gene has 4 transcripts (splice variants), three of 
which either skips an exon or are truncated versions.  
The actual protein coding transcript is 1617 bp long 
(NM_205850.2). 
Protein 
Description 
SLC24A5 codes for a cation exchanger which is 500 
amino acid long (NP_995322). This protein is an 
intracellular potassium-dependent sodium/calcium 
exchanger with 2 large hydrophilic loops and 2 sets 
of multiple trans-membrane-spanning segments. 
Expression 
Due to its localization in the melanosomal 
membrane, OCA2 is thought to be expressed in the 
melanocytes. 
Localisation 
Oculocutaneous Albinism Ray K, et al. 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2016; 20(6) 357 
 
SLC24A5 is hypothesized to be present in the trans-
Golgi network of melanocytes. 
Function 
The precise function of SLC24A5 has not been 
elucidated till date. However, the potential functions 
include: (a) transporting 1 Ca2+ and 1 K+ to the 
melanosome in exchange for 4 cytoplasmic Na+ 
[Lamason RL et al., 2005]; (b) Influencing natural 
variation in skin pigmentation via a novel, unknown 
mechanism affecting cellular sterol levels [Wilson S 
et al., 2013]. 
Homology 
It belongs to Solute Carrier Family 24 
(http://www.guidetopharmacology.org/GRAC/Fami
lyDisplayForward?familyId=202). 
Mutations 
Germinal 
SLC24A5 mutations are responsible for OCA6. 
LRMDA (leucine rich melanocyte 
differentiation associated) 
Alias 
Chromosome 10 Open Reading Frame, OCA7 
Location 
10q22.3 
Note 
C10Orf11 codes for a leucine rich repeat containing 
protein. 
DNA/RNA 
Description 
The human C10ORF11 gene consists of 6 exons and 
spans 959 kb of the genome. 
Transcription 
C10ORF11 encodes 16 splice variants of which 4 are 
protein coding and rest are processed transcripts. Of 
those 16, transcript variant 2 (Accession No: 
NM_032024.4) is 909 bp long and codes for a 198 
amino acids long peptide. 
Protein 
Description 
C10ORF11 encodes a 22.5 kDa protein (Accession 
No: NP_114413.1) composed of 198 amino acids. 
The sub-cellular localization of leucine rich repeat 
containing protein C10ORF11 is not clear. 
Expression 
This protein was found in melanoblast of embryo 
and melanocytes of fetus, but not in retinal pigment 
epithelial cells. 
Localisation 
C10ORF11 is hypothesized to be present in the 
melanosome, but not in retinal pigment epithelial 
cells. 
Function 
The precise function of C10ORF11 has not been 
elucidated till date. However, there is some evidence 
that it may play some role in melanocyte 
differentiation (Grønskov K et al., 2013). 
Mutations 
Germinal 
C10ORF11 mutations are responsible for OCA7. 
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